Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06199947
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-10
First Post:
2023-11-14
Brief Title:
Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma
Sponsor:
Poitiers University Hospital
Organization:
Poitiers University Hospital
Study Overview
Official Title:
Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The ROMCOR study will be interested in the impact and the role of oncostatin M OSM a cytokine belonging to IL-6 superfamily in the physiopathology of head and neck squamous cell carcinoma The study team will study the impact of the presence of OSM and its main receptor OSM-R2 on several survival outcomes overall survival progression free survival by multiple technics such as immunohistochemistry transcriptomic in situ assays and spatial transcriptomic Furthermore the study team will try to show a link between serum level of several cytokines and in situ tumoral OSM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None